StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Thanks for the 150,000 $0.05 warrants!!!

<< Previous

Bullboard Posts

Next >>

Comment by RelevantStockon Apr 07, 2021 6:14pm

122 Views

Post# 32954070

RE:RE:RE:RE:RE:Thanks for the 150,000 $0.05 warrants!!!

LithLover wrote: I
If it wasn't for the bashers I might have sold to but it just shows me there is a short here which we will take advantage of when it moves back up.

Same here, I still have a large part of my shares I'll keep them to see where this story ends. The acquisition and the plan is good. I am troubled by the fact that Tripp knew that we needed to be able to treat the patients for regulatory compliance a couple of light years ago and the plan he exposed to us and Clarus did not have that important variable in it.

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024